Low-dose stavudine trials: a public health priority for developing countries
The debate around relooking at stavudine dosing, both in terms of the adult low-dose stavudine study and more broadly, is welcome. The study being proposed to evaluate low-dose stavudine v. tenofovir is a fairly standard placebo-controlled non-inferiority study. The study design is not controversial...
|Main Authors:||, ,|
|Series:||Southern African Journal of HIV Medicine|